Literature DB >> 25549084

Dwell time modulation restrictions do not necessarily improve treatment plan quality for prostate HDR brachytherapy.

Marleen Balvert1, Bram L Gorissen, Dick den Hertog, Aswin L Hoffmann.   

Abstract

Inverse planning algorithms for dwell time optimisation in interstitial high-dose-rate (HDR) brachytherapy may produce solutions with large dwell time variations within catheters, which may result in undesirable selective high-dose subvolumes. Extending the dwell time optimisation model with a dwell time modulation restriction (DTMR) that limits dwell time differences between neighboring dwell positions has been suggested to eliminate this problem. DTMRs may additionally reduce the sensitivity for uncertainties in dwell positions that inevitably result from catheter reconstruction errors and afterloader source positioning inaccuracies. This study quantifies the reduction of high-dose subvolumes and the robustness against these uncertainties by applying a DTMR to template-based prostate HDR brachytherapy implants. Three different DTMRs were consecutively applied to a linear dose-based penalty model (LD) and a dose-volume based model (LDV), both obtained from literature. The models were solved with DTMR levels ranging from no restriction to uniform dwell times within catheters in discrete steps. Uncertainties were simulated on clinical cases using in-house developed software, and dose-volume metrics were calculated in each simulation. For the assessment of high-dose subvolumes, the dose homogeneity index (DHI) and the contiguous dose volume histogram were analysed. Robustness was measured by the improvement of the lowest D90% of the planning target volume (PTV) observed in the simulations. For (LD), a DTMR yields an increase in DHI of approximately 30% and reduces the size of the largest high-dose volume by 2-5 cc. However, this comes at a cost of a reduction in D90% of the PTV of 10%, which often implies that it drops below the desired minimum of 100%. For (LDV), none of the DTMRs were able to improve high-dose volume measures. DTMRs were not capable of improving robustness of PTV D90% against uncertainty in dwell positions for both models.

Entities:  

Mesh:

Year:  2014        PMID: 25549084     DOI: 10.1088/0031-9155/60/2/537

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  5 in total

1.  Influence of dwell time homogeneity error weight parameter on treatment plan quality in inverse optimized high-dose-rate cervix brachytherapy using SagiPlan.

Authors:  Mohammad Amin Mosleh-Shirazi; Elham Shahcheraghi-Motlagh; Mohammad Hadi Gholami; Alireza Shakibafard; Sareh Karbasi; Reza Fardid
Journal:  J Contemp Brachytherapy       Date:  2019-06-28

2.  An extended dose-volume model in high dose-rate brachytherapy - Using mean-tail-dose to reduce tumor underdosage.

Authors:  Björn Morén; Torbjörn Larsson; Åsa Carlsson Tedgren
Journal:  Med Phys       Date:  2019-05-15       Impact factor: 4.071

3.  Does inverse planning improve plan quality in interstitial high-dose-rate breast brachytherapy?

Authors:  Tibor Major; Georgina Fröhlich; Norbert Mészáros; Viktor Smanykó; Csaba Polgár
Journal:  J Contemp Brachytherapy       Date:  2020-04-30

4.  Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy.

Authors:  Chang Heon Choi; So-Yeon Park; Jong Min Park; Hong-Gyun Wu; Jin-Ho Kim; Jung-In Kim
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

5.  An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy.

Authors:  Xianliang Wang; Pei Wang; Bin Tang; Shengwei Kang; Qing Hou; Zhangwen Wu; Chengjun Gou; Lintao Li; Lucia Orlandini; Jinyi Lang; Jie Li
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.